Trial Profile
Single Dose and Multiple Dose Safety, Pharmacokinetics and Pharmacodynamics of Aprocitentan in Healthy Adult and Elderly Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Aprocitentan (Primary)
- Indications Cardiovascular disorders; Hypertension
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 29 Mar 2018 New trial record
- 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.